Articles

  • Jan 15, 2025 | wsj.com | Ore Huiying

    Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s disease, an inflammatory bowel disease that causes chronic abdominal pain. The treatment, developed by the pharmaceutical company under the brand name Omvoh, is now approved to treat two types of inflammatory bowel disease in the U.S., the Indianapolis company said Wednesday. The drug was previously approved to treat ulcerative colitis in adults in October 2023.

  • Nov 9, 2024 | nytimes.com | Mike Ives |Ore Huiying

    Xinderella the foster cat has a microchip, a human guardian and a stable home, but she lives in a state of regulatory limbo. Under murky new rules governing cats in Singapore's public housing, she is not registered to the apartment where she sleeps. The plucky, three-legged tabby is one of an unknown number of cats that recently became legal to keep as pets in Singapore, where more than four in five residents live in public housing.

  • Aug 2, 2024 | phillytrib.com | Ore Huiying

    We're always interested in hearing about news in our community. Let us know what's going on!

  • Feb 21, 2024 | nymag.com | Jen Wieczner |Ore Huiying

    Exponential Interactive, Inc d/b/a VDX.tvCookie duration: 90 (days). Data collected and processed: Browsing and interaction data, IP addresses, Non-precise location data, Device identifiers, Privacy choices, Users’ profiles, Probabilistic identifiersmoreCookie duration resets each session. View details | Storage details | Privacy policylaunchConsentCookie duration: 365 (days).

  • Dec 14, 2023 | buffalonews.com | Ore Huiying

    Facebook Twitter WhatsApp SMS Email Print Save FILE — Offices for ByteDance, the Chinese parent company of the social media video app TikTok, in Singapore, Jan. 26, 2023. TikTok removed rules that had required user disputes to be handled through private arbitration and instead said that complaints must be filed in one of two California courts.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →